These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 26253780

  • 1. Mid-Term Vascular Safety of Renal Denervation Assessed by Follow-up MR Imaging.
    Schmid A, Schmieder R, Lell M, Janka R, Veelken R, Schmieder RE, Uder M, Ott C.
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):426-32. PubMed ID: 26253780
    [Abstract] [Full Text] [Related]

  • 2. Renal denervation in moderate treatment-resistant hypertension.
    Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.
    J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901
    [Abstract] [Full Text] [Related]

  • 3. Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension.
    Hering D, Marusic P, Walton AS, Duval J, Lee R, Sata Y, Krum H, Lambert E, Peter K, Head G, Lambert G, Esler MD, Schlaich MP.
    Int J Cardiol; 2016 Jan 01; 202():388-93. PubMed ID: 26432488
    [Abstract] [Full Text] [Related]

  • 4. The effect of two different renal denervation strategies on blood pressure in resistant hypertension: Comparison of full-length versus proximal renal artery ablation.
    Chen W, Ling Z, Du H, Song W, Xu Y, Liu Z, Su L, Xiao P, Yuan Y, Lu J, Zhang J, Li Z, Shao J, Zhong B, Zhou B, Woo K, Yin Y.
    Catheter Cardiovasc Interv; 2016 Nov 01; 88(5):786-795. PubMed ID: 27219520
    [Abstract] [Full Text] [Related]

  • 5. Accessory renal arteries: Prevalence in resistant hypertension and an important role in nonresponse to radiofrequency renal denervation.
    VonAchen P, Hamann J, Houghland T, Lesser JR, Wang Y, Caye D, Rosenthal K, Garberich RF, Daniels M, Schwartz RS.
    Cardiovasc Revasc Med; 2016 Nov 01; 17(7):470-473. PubMed ID: 27493150
    [Abstract] [Full Text] [Related]

  • 6. Impact of renal denervation on tissue Na+ content in treatment-resistant hypertension.
    Ott C, Kopp C, Dahlmann A, Schmid A, Linz P, Cavallaro A, Hammon M, Ditting T, Veelken R, Uder M, Titze J, Schmieder RE.
    Clin Res Cardiol; 2018 Jan 01; 107(1):42-48. PubMed ID: 28845508
    [Abstract] [Full Text] [Related]

  • 7. Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner.
    Schirmer SH, Sayed MM, Reil JC, Lavall D, Ukena C, Linz D, Mahfoud F, Böhm M.
    JACC Cardiovasc Interv; 2015 Jun 01; 8(7):972-80. PubMed ID: 26003031
    [Abstract] [Full Text] [Related]

  • 8. Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency.
    Lauder L, Ewen S, Tzafriri AR, Edelman ER, Cremers B, Kulenthiran S, Ukena C, Linz D, Kindermann I, Tsioufis C, Scheller B, Böhm M, Mahfoud F.
    Cardiovasc Revasc Med; 2018 Jun 01; 19(7 Pt B):845-851. PubMed ID: 29555535
    [Abstract] [Full Text] [Related]

  • 9. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
    Fengler K, Rommel KP, Lapusca R, Blazek S, Besler C, Hartung P, von Roeder M, Kresoja KP, Desch S, Thiele H, Lurz P.
    Hypertension; 2019 Aug 01; 74(2):341-348. PubMed ID: 31203726
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
    Bhatt DL, Vaduganathan M, Kandzari DE, Leon MB, Rocha-Singh K, Townsend RR, Katzen BT, Oparil S, Brar S, DeBruin V, Fahy M, Bakris GL, SYMPLICITY HTN-3 Steering Committee Investigators.
    Lancet; 2022 Oct 22; 400(10361):1405-1416. PubMed ID: 36130612
    [Abstract] [Full Text] [Related]

  • 11. Does renal artery supply indicate treatment success of renal denervation?
    Schmid A, Ditting T, Sobotka PA, Veelken R, Schmieder RE, Uder M, Ott C.
    Cardiovasc Intervent Radiol; 2013 Aug 22; 36(4):987-91. PubMed ID: 23771326
    [Abstract] [Full Text] [Related]

  • 12. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R.
    EuroIntervention; 2012 Jan 22; 7(9):1077-80. PubMed ID: 21959556
    [Abstract] [Full Text] [Related]

  • 13. Renal denervation.
    Olsen LK, Kamper AL, Svendsen JH, Feldt-Rasmussen B.
    Eur J Intern Med; 2015 Mar 22; 26(2):95-105. PubMed ID: 25676808
    [Abstract] [Full Text] [Related]

  • 14. Impact of local vascular lesions assessed with optical coherence tomography and ablation points on blood pressure reduction after renal denervation.
    Ghadri JR, Gaehwiler R, Jaguszewski M, Sudano I, Osipova J, Schoenenberger-Berzins R, Erne P, Lüscher TF, Templin C.
    Swiss Med Wkly; 2015 Mar 22; 145():w14102. PubMed ID: 25658048
    [Abstract] [Full Text] [Related]

  • 15. Improvement of albuminuria after renal denervation.
    Ott C, Mahfoud F, Schmid A, Ditting T, Veelken R, Ewen S, Ukena C, Uder M, Böhm M, Schmieder RE.
    Int J Cardiol; 2014 May 01; 173(2):311-5. PubMed ID: 24681017
    [Abstract] [Full Text] [Related]

  • 16. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A.
    Hypertension; 2014 May 01; 63(5):991-9. PubMed ID: 24591332
    [Abstract] [Full Text] [Related]

  • 17. Ultrasound-based renal sympathetic denervation for the treatment of therapy-resistant hypertension: a single-center experience.
    Fengler K, Höllriegel R, Okon T, Stiermaier T, Rommel KP, Blazek S, Besler C, von Roeder M, Petzold M, Schuler G, Lurz P.
    J Hypertens; 2017 Jun 01; 35(6):1310-1317. PubMed ID: 28441700
    [Abstract] [Full Text] [Related]

  • 18. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
    Donazzan L, Mahfoud F, Ewen S, Ukena C, Cremers B, Kirsch CM, Hellwig D, Eweiwi T, Ezziddin S, Esler M, Böhm M.
    Clin Res Cardiol; 2016 Apr 01; 105(4):364-71. PubMed ID: 26493305
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries.
    Mahfoud F, Tunev S, Ruwart J, Schulz-Jander D, Cremers B, Linz D, Zeller T, Bhatt DL, Rocha-Singh K, Böhm M, Melder RJ.
    Circ Cardiovasc Interv; 2014 Dec 01; 7(6):813-20. PubMed ID: 25336466
    [Abstract] [Full Text] [Related]

  • 20. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
    Lenski M, Mahfoud F, Razouk A, Ukena C, Lenski D, Barth C, Linz D, Laufs U, Kindermann I, Böhm M.
    Int J Cardiol; 2013 Nov 30; 169(6):418-24. PubMed ID: 24157238
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.